Cost and compliance may be colliding but, with the right strategy, organisations can navigate this intersection effectively.

Understanding that communication and transparency from experts are critical enablers for widespread confidence in AI is the ...

Madrigal Pharma could be just weeks away from becoming the first drugmaker to claim EU approval for a treatment for metabolic ...

Grail is preparing to file for FDA approval of its Galleri test for detecting multiple cancers from a single blood test after ...

IL-4 and IL-13 inhibitor Dupixent (dupilumab) is the first biologic drug to show an improvement in remission and symptoms in ...

The FDA has launched a review of clinical trials that plan to send American citizens' living cells to 'hostile' countries – ...

After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more ...

It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ...

Participants are vital to the success of any clinical trial. Without the data they provide, our research system would collapse. But being a clinical trial participant is not easy. Financial ...

The end of the line is looming for Oxurion, after a clinical trial of its last pipeline drug for diabetic macular oedema (DME) failed to meet its primary endpoint. With its cash reserves dwindling ...

The FDA has released its recommendations on the composition of influenza vaccines for the 2025-26 season – without the input of its external advisors. The Vaccines and Related Biological ...